Total liabilities · 2018–2025
Bridgebio Pharma total liabilities
$3.0B+26.7% · FY2025
Bridgebio Pharma (BBIO) reported $3.0B in total liabilities for fiscal 2025, +26.7% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $3.0B | +26.7% | Open → |
| FY20242024-12-31 | $2.4B | +25.8% | Open → |
| FY20232023-12-31 | $1.9B | +1.1% | Open → |
| FY20222022-12-31 | $1.9B | −0.6% | Open → |
| FY20212021-12-31 | $1.9B | +215.3% | Open → |
| FY20202020-12-31 | $596M | +282.6% | Open → |
| FY20192019-12-31 | $156M | +77.8% | Open → |
| FY20182018-12-31 | $87.6M | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2018–2025 compound annual growth +65.8%
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Bridgebio Pharma total liabilities |url=https://companiesranked.com/en/company/bridgebio-pharma/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Bridgebio Pharma total liabilities. CompaniesRanked. https://companiesranked.com/en/company/bridgebio-pharma/total-liabilitiesBibTeX
@misc{companiesranked-en-company-bridgebio-pharma-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Bridgebio Pharma total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/bridgebio-pharma/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001743881-26-000027 · August 10, 2026
{{cite web |title=Bridgebio Pharma total liabilities — 10-Q (0001743881-26-000027) |url=https://www.sec.gov/Archives/edgar/data/1743881/000174388126000027/bbio-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-10}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.